A year after the FTC killed Pacific Biosciences’ $1.2 billion buyout by Illumina, California’s smaller genomic sequencing company has found a far different group to fork over a fortune.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,